D-Heart
Genova
About D-Heart
D-Heart is the first smartphone ECG device that simple to use, clinically reliable, portable and affordable. It allows anyone to perform a hospital-level ECG in total autonomy and to send the results to the 24/7 tele-cardiology service or to your trusted doctor. D-Heart biomedical start-up was founded in 2015 thanks to the work of Nicolò Briante and Niccolò Maurizi, at the time two young students in the interdisciplinary environment of the Almo Collegio Borromeo of Pavia. Maurizi, a young doctor researcher in cardiology at the University of Florence, When he was sixteen, Maurizi was hit by a myocardial infraction. He decided to became a doctor and transform his problem into an opportunity. Thanks to the help and business expertise of his roommate, Briante, they created D-Heart, the first smartphone ECG device that combines the usability required by the patient and reliability of the ECG wanted by the doctor.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Oct 2018)
- Website: d-heartcare.com
- Phone: +39 010 3017000
Industries & Categories
CRM, Health Care, Information Technology, Mobile
Social Profiles
Canonical: https://fsome.com/organization/d-heart-2434551 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.